We are live on ! Find out more
KA

Kinnevik AB Portfolio holdings

AUM $65.6M
1-Year Est. Return 25.95%
This Fund
S&P 500
This Quarter Est. Return
-19.99%
1 Year Est. Return
-25.95%
3 Year Est. Return
-51.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$177M
AUM Growth
+$58M
Cap. Flow
+$103M
Cap. Flow %
58.26%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RXRX icon
Recursion Pharmaceuticals
RXRX
+$75M
2
BBLN
Babylon Holdings Limited
BBLN
+$28.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDOC icon
1
Teladoc Health
TDOC
$1.19B
$87.1M 49.14%
3,683,668
– –
RXRX icon
2
Recursion Pharmaceuticals
RXRX
$1.61B
$59M 33.28%
+7,653,061
New +$75M
BBLN
3
DELISTED
Babylon Holdings Limited
BBLN
$31.2M 17.58%
4,617,340
+2,419,637
+110% +$28.2M

Similar funds

TCP
Teleios Capital Partners Zug $65.7M AUM 48.76% 1-Year Est. Return
MMC
Mainsail Management Company Austin, Texas $66M AUM 18.6% 1-Year Est. Return
MIG
Mithril II GP Austin, Texas $64.5M AUM 360.75% 1-Year Est. Return
KAM
Kinney Asset Management Chicago, Illinois $67.1M AUM 29.09% 1-Year Est. Return
MA
MAS Advisors Miami, Florida $63.2M AUM 9.63% 1-Year Est. Return
EVP
Evergreen Venture Partners Tel Aviv, Israel $68.4M AUM 1.49% 1-Year Est. Return
TIM
Tikehau Investment Management Paris, France $68.4M AUM 23.35% 1-Year Est. Return
A
Atomvest Hong Kong $68.5M AUM 4.6% 1-Year Est. Return

Kinnevik AB's Q4 2022 Portfolio in Review

As of Q4 2022, Kinnevik AB held 3 positions worth $177M, up 49% from $119M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Kinnevik AB deployed $103M of net new capital in Q4 2022, opening 1 new position and adding to 1 existing holding. Its largest new stake was Recursion Pharmaceuticals: 7,653,061 shares worth $59M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Kinnevik AB's largest Q4 2022 buy was Recursion Pharmaceuticals: 7,653,061 shares worth $59M.
  • Kinnevik AB added most to Babylon Holdings Limited in Q4 2022, an estimated $28.2M increase.
  • Kinnevik AB's ten largest holdings make up 100% of its $177M portfolio in Q4 2022.
  • Kinnevik AB opened 1 new position and closed 0 in Q4 2022.
  • Kinnevik AB's portfolio value rose 49% quarter-over-quarter to $177M.

Based on Kinnevik AB's 13F filing for Q4 2022, filed 1 Feb 2023.